Ashwell SG - Search Results

1

The efficacy and safety of lanreotide Autogel in patients with acromegaly previously treated with octreotide LAR.

Ashwell SG, Bevan JS, Edwards OM, Harris MM, Holmes C, Middleton MA, James RA. Ashwell SG, et al. Eur J Endocrinol. 2004 Apr;150(4):473-80. doi: 10.1530/eje.0.1500473. Eur J Endocrinol. 2004. PMID: 15080776 Clinical Trial.

2

Residual Adrenal Function in Autoimmune Addison's Disease-Effect of Dual Therapy With Rituximab and Depot Tetracosactide.

Napier C, Gan EH, Mitchell AL, Gilligan LC, Rees DA, Moran C, Chatterjee K, Vaidya B, James RA, Mamoojee Y, Ashwell S, Arlt W, Pearce SHS. Napier C, et al. J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1250-9. doi: 10.1210/clinem/dgz287. J Clin Endocrinol Metab. 2020. PMID: 31863094 Free PMC article.

3

Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.

Ashwell SG, Gebbie J, Home PD. Ashwell SG, et al. Diabet Med. 2006 Aug;23(8):879-86. doi: 10.1111/j.1464-5491.2006.01913.x. Diabet Med. 2006. PMID: 16911626 Clinical Trial.

4

Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial.

Dashora UK, Sibal L, Ashwell SG, Home PD. Dashora UK, et al. Among authors: ashwell sg. Diabet Med. 2007 Apr;24(4):344-9. doi: 10.1111/j.1464-5491.2007.02094.x. Epub 2007 Jan 12. Diabet Med. 2007. PMID: 17298589 Clinical Trial.

5

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes.

Ashwell SG, Amiel SA, Bilous RW, Dashora U, Heller SR, Hepburn DA, Shutler SD, Stephens JW, Home PD. Ashwell SG, et al. Diabet Med. 2006 Mar;23(3):285-92. doi: 10.1111/j.1464-5491.2005.01781.x. Diabet Med. 2006. PMID: 16492212 Clinical Trial.

6

Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times.

Ashwell SG, Gebbie J, Home PD. Ashwell SG, et al. Diabet Med. 2006 Jan;23(1):46-52. doi: 10.1111/j.1464-5491.2005.01726.x. Diabet Med. 2006. PMID: 16409565 Clinical Trial.

7

Insulin glargine: the first clinically useful extended-action insulin analogue.

Ashwell SG, Home PD. Ashwell SG, et al. Expert Opin Pharmacother. 2001 Nov;2(11):1891-902. doi: 10.1517/14656566.2.11.1891. Expert Opin Pharmacother. 2001. PMID: 11825324 Review.

8

An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes.

Dashora U, Ashwell SG, Home PD. Dashora U, et al. Among authors: ashwell sg. Diabetes Obes Metab. 2009 Jul;11(7):680-7. doi: 10.1111/j.1463-1326.2008.01024.x. Diabetes Obes Metab. 2009. PMID: 19527481 Clinical Trial.

9

Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes.

Ashwell SG, Bradley C, Stephens JW, Witthaus E, Home PD. Ashwell SG, et al. Diabetes Care. 2008 Jun;31(6):1112-7. doi: 10.2337/dc07-1183. Epub 2008 Mar 13. Diabetes Care. 2008. PMID: 18339977 Clinical Trial.

10

An overview of insulin glargine.

Home PD, Ashwell SG. Home PD, et al. Among authors: ashwell sg. Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S57-63. doi: 10.1002/dmrr.317. Diabetes Metab Res Rev. 2002. PMID: 12324987 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters